Q/C Technologies, Inc. (QCLS)
0.50
0.00 (0.00%)
USD |
NASDAQ |
Oct 20, 16:00
0.52
+0.02
(+4.00%)
After-Hours: 06:53
Q/C Technologies Enterprise Value : -3.393M for Oct. 20, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 20, 2026 | -3.393M |
| October 19, 2026 | -3.393M |
| October 16, 2026 | -3.080M |
| October 15, 2026 | -2.922M |
| October 14, 2026 | -3.069M |
| October 13, 2026 | -3.013M |
| October 12, 2026 | -2.737M |
| October 09, 2026 | -2.329M |
| October 08, 2026 | -2.274M |
| October 07, 2026 | -2.312M |
| October 06, 2026 | -1.836M |
| October 05, 2026 | -1.915M |
| October 02, 2026 | -1.362M |
| October 01, 2026 | -1.139M |
| September 30, 2026 | -0.518M |
| September 29, 2026 | -0.1724M |
| September 28, 2026 | -0.667M |
| September 25, 2026 | -0.3812M |
| September 24, 2026 | 0.8653M |
| September 23, 2026 | -0.2862M |
| September 22, 2026 | -0.1781M |
| September 21, 2026 | -1.062M |
| September 18, 2026 | -1.237M |
| September 17, 2026 | -1.264M |
| September 16, 2026 | 0.4067M |
| Date | Value |
|---|---|
| September 15, 2026 | -3.874M |
| September 14, 2026 | -2.901M |
| September 11, 2026 | 6.516M |
| September 10, 2026 | 6.025M |
| September 09, 2026 | 7.090M |
| September 08, 2026 | 8.318M |
| September 04, 2026 | 7.171M |
| September 03, 2026 | 7.908M |
| September 02, 2026 | 8.154M |
| September 01, 2026 | 9.628M |
| August 31, 2026 | 11.51M |
| August 28, 2026 | 11.76M |
| August 27, 2026 | 11.92M |
| August 26, 2026 | 12.90M |
| August 25, 2026 | 12.49M |
| August 24, 2026 | 12.25M |
| August 21, 2026 | 13.64M |
| August 20, 2026 | 14.87M |
| August 19, 2026 | 14.54M |
| August 18, 2026 | 14.54M |
| August 17, 2026 | 15.52M |
| August 14, 2026 | 15.20M |
| August 13, 2026 | 15.93M |
| August 12, 2026 | 16.18M |
| August 11, 2026 | 16.18M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.904B |
| Corcept Therapeutics, Inc. | 12.27B |
| Veru, Inc. | 17.47M |
| Johnson & Johnson | 652.88B |
| Eli Lilly & Co. | 1.255T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.616M |
| Total Expenses (Quarterly) | 6.616M |
| EPS Diluted (Quarterly) | -0.794 |
| Earnings Yield | -868.0% |
| Normalized Earnings Yield | -683.22 |